Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Colorectal Neoplasms 3Brain Neoplasms 3Rectal Neoplasms 2Pain, Postoperative 2Neurotoxicity Syndromes 2Neoplasms 2Mesothelioma 2Colonic Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Upper Abdominal Cancer Surgery 1Thyroid Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Immunodeficiency Diseases 1Pain 1Paclitaxel-induced Neuropathy 1Myoma 1Leukemia, Myeloid, Acute 1Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Colorectal Cancer Screening 1Anesthesia 1

Interventions

Magnesium Sulfate 1Magnesium 1Calcium Gluconate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Paclitaxel-induced Neuropathy × Magnesium Sulfate × Clear all
NCT01682499 2014-09-25

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Beth Israel Medical Center

Phase 1 Completed
50 enrolled

Paclitaxel-induced Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡